Novartis refreshes Kisqali metastatic breast cancer campaign with message to both ‘live longer and live well’news2023-10-25T19:09:59+00:00October 25th, 2023|Endpoints News|
GSK says RSV vaccine triggered immune response in adults as young as 50 years oldnews2023-10-25T19:00:41+00:00October 25th, 2023|Endpoints News|
GHMC healthcare network expands south, partners with Mexico-based agencynews2023-10-25T17:08:53+00:00October 25th, 2023|Endpoints News|
NIH nominee Monica Bertagnolli clears Senate panel with bipartisan support despite Sanders’ drug pricing qualmsnews2023-10-25T17:00:19+00:00October 25th, 2023|Endpoints News|
Excision’s HIV gene editing clinical trial; Nykode’s $45M placement; Ideaya’s post-ESMO offeringnews2023-10-25T15:22:15+00:00October 25th, 2023|Endpoints News|
BioXcel says independent audit of Alzheimer’s study found misconduct did not impact data reliabilitynews2023-10-25T15:02:17+00:00October 25th, 2023|Endpoints News|
Biogen reports positive signs from early study of tau-lowering drugnews2023-10-25T14:50:33+00:00October 25th, 2023|Endpoints News|
Merck ends PhII trials of Alzheimer’s and depression small molecule after liver toxicity observationsnews2023-10-25T14:47:24+00:00October 25th, 2023|Endpoints News|
How Bristol Myers’ buyout offer for Mirati dwindled by billions of dollarsnews2023-10-25T14:46:36+00:00October 25th, 2023|Endpoints News|
Danaher’s third-quarter revenue from biotech services down 19% amid slowdown in China, USnews2023-10-25T11:20:46+00:00October 25th, 2023|Endpoints News|
